PAH Endokrinologie

ENDOKRINOLOGIEZENTRUM MÜNCHEN

Prof. Dr. med. K. Mann

 

 GP Alter Hof Logos Gesamt DUNKEL 2013 10 Kardiologie Nuklearmedizin Hypertonie Endokrinologie Lipidologie

Ausgewählte Publikationen

Originalarbeiten

Graf D, Helmich-Kapp B, Graf S, Veith F, Lehmann N, Mann K.
Funktionelle Aktivität fokaler Schilddrüsenautonomien in Deutschland.
Dtsch Med Wochenschr 2012; 137: 2089 – 2092

Benson S, Neumann P, Unger N, Schedlowski M, Mann K, Elsenbruch S, Petersenn S.
Effects of standard glucocorticoid replacement therapies on subjective well-being:
A randomized, double-blind cross-over study in patients with secondary adrenal insufficency.
Eur J Endocrinol 2012 Aug 28

Petersenn S, Hu K, Maldonado M, Zhang Y, Lasher J, Bouillaud E, Wang Y, Mann K. Unger N.
Tolerability and dose proportional pharmacokinetics of pasireotide administered as a single dose or two divided doses in healthy male volunteers: a single-center, open-label, ascending-dose study.
Clin Ther 2012;34(3):677-688

Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K, Petersenn S.
Salivary cortisol as diagnostic tool for Cushing`s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
Eur J Endocrinol 2012; 166(4):613-618

Poeppel TD, Yuece A, Boy C, Metz KA, Kaminsky E, Neumann HP, Rosenbaum SJ, Mann K, Moeller LC.
Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy.
J Clin Oncol 2011; 29(33):e812-815


Dlugaj M, Gerwig M, Wege N, Siegrist J, Mann K, Bröcker-Preuss M, Dragano N, Moebus S, Jöckel KH, Bokhof B, Möhlenkamp S, Erbel R, Weimar C.
Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study.
J Alzheimers Dis 2012;28(3):503-514

Petersenn S, Unger N, Hu K, Weisshaar B, Zhang Y, Bouillaud E, Reséndiz KH, Wang Y, Mann K.
Pasireotide (SOM230), a novel multireceptor-targeted somatostatin analogue, ist well tolerated when administered as a continuous 7-day subcutaneous infusion in healthy male volunteers
J Clin Pharmacol 2012;52(7):1017-1027

Kälsch H, Lehman N, Möhlenkamp S, Becker A, Moebus S, Schmermund A, Stang A, Mahabadi AA, Mann K, Jöckel KH, Erbel R, Eggebrecht H.#
Body-surface adjusted aortic reference diameters for improved identification of patiens with thoracic aortic aneurysms: Results from the population-based Heinz Nixdorf Recall study.
Int j Cardiol 2011

Möhlenkamp S, Lehmann N, Moebus S, Schmermund A, Dragano N, Stand A, Siegrist J, Mann K, Jöckel KH, Ebel R, Heinz Nixdorf Recall Study Investigators.
Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality.
J Am Coll Cardiol 2011;57(13):1455-1464


Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, Brandau W, Mann K, Antoch G, Bockisch A, Petersenn S.
68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax.
Eur J Nucl Med Mol Imaging 2011;38(7):1224-1236

Möhlenkamp S, Lehmann N, Greenland P, Moebus S, Kälsch H, Schmermund A, Drageno N, Stang A, Siegrist J, Mann K, Jöckel KH, Erbel R; Heinz Nixdorf Recall Study Investigators.
Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy.
Atherosclerosis 2011;215(1):229-236

Kratzsch J, Petzold A, Raue F, Reinhardt W, Bröcker-Preuss M, Görges R, Mann K, Karges W, Morgenthaler N, Luster M, Reiners C, Thiery J, Dralle H, Fuhrer D.
Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Clin Chem 2011;57(3):467-474

Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stand A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group.
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study.
J Am Coll Cardiol 2010;56(17):1397-1406

Pechlivanis S, Scherag A, Mühleisen TW, Möhlenkamp S, Horsthemke B, Boes T, Bröcker-Preuss M, Mann K, Erbel R, Jöckel KH, Nöthen MM, Moebus S; Heinz Nixdorf Recall Study Group.
Coronary artery calcification and its relationship to validated genetic variants for diabetes mellitus assessed in the Heinz Nixdorf recall cohort.
Arterioscler Thromb Vasc Biol 2010;30(9):1867-1972

Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M, Stalla GK, Strasburger CJ, Roggenbuck U, Lehmann N, Moebus S, Jöckel KH, Möhlenkamp S, Erbel R, Saller B, Mann K; Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigtors.
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.
J Clin Endocinol Metab 2010;95(8):3648-3656


Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salagado LR, Biller BM; Pasireotide B2305 Study Group.
A 12-month phase 3 study of pasireotide in Cushing`s disease.
N Engl J Med 2012;366(10):914-924

Kontakt

PRAXIS ALTER HOF MÜNCHEN
Dienerstraße 12 · 80331 München
Tel. 089 2166918 - 0
info@praxis-alter-hof.de

Ihr Weg in die Praxis

googlemaos 

TÜV Zertifizierung

91 ISO9001 rgb 120